The Banff 2017 Kidney Meeting Report : Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
-
Haas, Mark (Cedars-Sinai Medical Center)
;
Loupy, Alexandre (University Paris Descartes. INSERM U970 and Necker Hospital. Paris Translational Research Center for Organ Transplantation) ;
Lefaucheur, Carmen (Université Paris VII and INSERM U 1160. Hopital Saint Louis) ;
Roufosse, C. (Imperial College London and North West London Pathology) ;
Glotz, Denis (Université Paris VII and INSERM U 1160. Hopital Saint Louis) ;
Serón Micas, Daniel (Hospital Universitari Vall d'Hebron) ;
Nankivell, B. J. (Westmead Hospital) ;
Halloran, P. F. (University of Alberta) ;
Colvin, Robert (Harvard Medical School) ;
Akalin, Enver (Montefiore Medical Center) ;
Alachkar, Nada (Johns Hopkins University School of Medicine) ;
Bagnasco, Serena (Johns Hopkins University School of Medicine) ;
Bouatou, Y. (Geneva University Hospitals (Suïssa)) ;
Becker, Jan U (Uniklinik Köln (Colònia, Alemanya)) ;
Cornell, Lynn (Mayo Clinic) ;
van Huyen, J. P. Duong (University Paris Descartes. INSERM U970 and Necker Hospital. Paris Translational Research Center for Organ Transplantation) ;
Gibson, Ian W (University of Manitoba) ;
Kraus, Edward S. (Johns Hopkins University) ;
Mannon, R. B. (University of Alabama School of Medicine) ;
Naesens, Maarten (University Hospitals Leuven (Bèlgica)) ;
Nickeleit, V. (The University of North Carolina School of Medicine) ;
Nickerson, P. (University of Manitoba) ;
Segev, D. L. (Johns Hopkins Medical Institutions) ;
Singh, H. K. (The University of North Carolina School of Medicine) ;
Stegall, M. (Mayo Clinic) ;
Randhawa, P. (University of Pittsburgh) ;
Racusen, L. (Johns Hopkins University School of Medicine) ;
Solez, Kim (University of Alberta) ;
Mengel, Michael (University of Alberta) ;
Universitat Autònoma de Barcelona
visitante ::
identificación
Subscribirse to this discussion. You will then receive all new comments by email.
